Latest news with #660
GMA Network
4 days ago
- General
- GMA Network
No winners of major lotto draws on Friday, July 25, 2025
There were no winners of either of the major lotto jackpots offered on Friday, July 25, 2025, the Philippine Charity Sweepstakes Office (PCSO) announced. No bettor chose the winning combination of 05-30-19-43-51-50 picked for the Ultra Lotto 6/58 jackpot prize of P258,660,618.80. There was also no winner of the Megalotto 6/45 jackpot of P12,040,346.20, with the winning combination of 41-14-05-36-29-27. Click here for the complete lotto results. — BAP, GMA Integrated News
Yahoo
16-07-2025
- Entertainment
- Yahoo
Harry Potter and My Family star Zoë Wanamaker banned from driving at Wycombe court
Harry Potter and My Family star Zoë Wanamaker has been banned from driving at a court in High Wycombe. The actress was disqualified after she was caught driving at 46mph through an area of roadworks on the M4 Eastbound near Welford, Newbury. The court heard how a 40mph speed limit had been in place at the time of the offence at around 3.34pm on August 7 last year. READ MORE: Harry Potter star Emma Watson banned from driving for speeding at High Wycombe court The 77-year-old, who was born in New York City, USA, was disqualified from driving for six months due to previously totting up nine points. Prosecutor, Adrian Wilson told High Wycombe Magistrates' Court on Wednesday morning that she had previously committed three driving offences. Mr Wanamaker was also fined £660 and must pay a £254 surcharge plus £120 court costs. District Judge Arvind Sharma made a collection order for the outstanding funds. Her solicitor, Duncan Jones said: "She accepts she is going to be disqualified from driving." The actress is perhaps best known to international audiences as flying instructor Madam Rolanda Hooch, who featured in the series' first film, Harry Potter and the Philosopher's Stone, as well as Doctor Who in the role of Lady Cassandra O'Brien. She also starred in 114 episodes of the BBC sitcom My Family as Susan Harper alongside a cast including the likes of Robert Lindsay and Kris Marshall. Ms Wanamaker is appearing in 2025's reboot of Bergerac as Charlie Hungerford alongside Damien Molony in the titular role. Ms Wanamaker's Harry Potter co-star, Emma Watson, was also banned from driving at the same court just a short time before for speeding in Oxford.
Mint
30-05-2025
- Business
- Mint
Suzlon Energy share price rallies over 13% to 6-month high as Q4 net profit jumps nearly 5-fold
Shares of Suzlon Energy, one of the leading global renewable energy solutions providers, jumped 13.60% in early morning trade on Friday, May 30, after investors cheered the company's stellar March quarter performance, sending the stock to a six-month high. The company post market hours, reported a net profit of ₹ 1,181 crore for the quarter, compared to ₹ 254 crore in the same period last fiscal, marking a 365% year-on-year growth. Revenue from operations during the quarter rose 73% year-on-year to ₹ 3,774 crore. For FY25, Suzlon Energy's net profit jumped to ₹ 2,072 crore from ₹ 660 crore in FY24, driven by a ₹ 10,851 crore rise in revenue. The sharp jump in profit was primarily driven by a deferred tax gain of ₹ 601 crore during Q4, which significantly boosted the bottom line. In FY24, the company had reported a revenue of ₹ 6,497 crore. The WTG business accounted for 78% of FY25 revenue, while the remaining came from the OMS (Operations and Maintenance Services) business. On the operating front, EBITDA surged to ₹ 693 crore in Q4 FY25, taking the full-year EBITDA to ₹ 1,857 crore. Margins expanded by 200 basis points during the quarter and 130 basis points for the full year. The company achieved a record quarterly delivery of 573 MW, bringing total FY25 deliveries to 1.55 GW. Its order book reached a record high of 5.6 GW by the end of FY25, with the S144 platform alone surpassing 5 GW—cementing its position as the dominant product in the Indian market. The company said it added 10 new production lines for its S144 – 3.X MW series and completed nacelle expansions at its Daman and Pondicherry facilities. It also stated plans to continue investing in a robust local manufacturing and supply chain ecosystem to support India's wind energy ambitions. Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before taking any investment decisions.
Mint
29-05-2025
- Business
- Mint
Suzlon Energy Q4 Results: Net profit jumps to ₹1,181 crore, EBITDA rises 94% YoY
Suzlon Energy Q4 results in focus: Suzlon Energy, one of the leading global renewable energy solutions providers, released its March quarter and full-year (FY25) results today, May 29, reporting stellar figures, as the company continues to see a surge in demand for its S144 wind turbine. The company posted a net profit of ₹ 1,181 crore for the quarter, compared to ₹ 254 crore in the same period last fiscal, marking a 365% year-on-year growth. The sharp jump in profit was primarily driven by a deferred tax gain of ₹ 601 crore, which significantly boosted the bottom line. Revenue from operations during the quarter rose 73% year-on-year to ₹ 3,774 crore. For FY25, Suzlon Energy's net profit jumped to ₹ 2,072 crore from ₹ 660 crore in FY24, driven by a ₹ 10,851 crore rise in revenue. In FY24, the company had reported a revenue of ₹ 6,497 crore. The WTG business accounted for 78% of FY25 revenue, while the remaining came from the OMS (Operations and Maintenance Services) business. On the operating front, EBITDA surged to ₹ 693 crore in Q4 FY25, taking the full-year EBITDA to ₹ 1,857 crore. Margins expanded by 200 basis points during the quarter and 130 basis points for the full year. Suzlon's net cash position improved to ₹ 1,943 crore as of March 2025, up ₹ 836 crore compared to December 2024. The company achieved a record quarterly delivery of 573 MW, bringing total FY25 deliveries to 1.55 GW. Its order book reached a record high of 5.6 GW by the end of FY25, with the S144 platform alone surpassing 5 GW—cementing its position as the dominant product in the Indian market. The contribution margin from its WTG business expanded to 23%, marking a 360-basis point rise, supported by its 4.5 GW manufacturing capacity. The company said it added 10 new production lines for its S144 – 3.X MW series and completed nacelle expansions at its Daman and Pondicherry facilities. It also stated plans to continue investing in a robust local manufacturing and supply chain ecosystem to support India's wind energy ambitions.
Associated Press
29-05-2025
- Business
- Associated Press
Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully
- Over 1,000 investment and business matching meetings lined up underscoring Hong Kong's role as a healthcare investment hub - ASGH brought together more than 2,900 participants from 42 countries and regions - Medical Fair attracted some 13,000 buyers from 57 countries and regions - The two flagship events together resulted in over 390 deal-making sessions and more than 660 business matching meetings - Collaboration agreements were signed during the events, covering areas including patient care, diagnostic solutions, innovative medical devices, and medical imaging HONG KONG - May 28, 2025 ( NEWMEDIAWIRE ) - The fifth Asia Summit on Global Health (ASGH) and the 16th Hong Kong International Medical and Healthcare Fair (Medical Fair), both organised by the Hong Kong Trade Development Council (HKTDC), have drawn to a successful close. As flagship events of International Healthcare Week (IHW), both ASGH and the Medical Fair brought global healthcare stakeholders together, including government officials and organisations, research pioneers, investors, and business leaders. ASGH attracted over 2,900 participants from 42 countries and regions, while the Medical Fair received some 13,000 buyers from 57 countries and regions. Over 390 one-on-one deal-making sessions and more than 660 business matching meetings were arranged, facilitating over 1,000 high-quality collaborations and connections. The IHW continues to foster global exchange and cooperation, putting a spotlight on Hong Kong's vast potential in healthcare investment and trade, and reinforcing its position as a regional leading medical hub. Dr Peter K N Lam, Chairman of the HKTDC, said: 'The Asia Summit on Global Health and the Hong Kong International Medical and Healthcare Fair concluded with outstanding results driving new collaborations and investments, and injecting new momentum into the healthcare industry. The events brought together leaders across government, business, academia, and investment to tackle today's healthcare challenges, highlighting Hong Kong's unique advantages as an international innovation and technology hub under its 'eight centres' positioning, actively advancing medical technology, connecting global innovation resources, and paving the way for a healthier and more inclusive future.' Over 80 industry experts shared insights on healthcare development The two-day ASGH, jointly organised by the HKSAR Government and the HKTDC under the theme 'Fostering Global Collaboration for a Shared Future', focused on a wide spectrum of topics including public health, medical technology breakthroughs, healthy ageing and global business and investment collaboration. The event featured more than 80 speakers comprising government officials and organisations, research pioneers, investors, and business leaders from around the world, all contributing valuable insights to advance global well-being. Prof Lo Chung-mau, Secretary for Health of the HKSAR Government, delivered a keynote speech during the Plenary Session I: Shaping a More Equitable and Sustainable Health System. Other distinguished speakers, including Dr Wu Xiaobin, Vice President of China Pharmaceutical Innovation and Research Development Association; Martin Taylor, Representative to China, World Health Organization; Prof Nancy Ip, President of the Hong Kong University of Science and Technology; and Frédéric Rimattei, Special Envoy for International Affairs of the President of French University Hospitals National Association, shared their insights on tackling global healthcare challenges, offering inspiration for the international healthcare community. In Plenary Session II: Fostering Global Collaboration for a Shared Future, speakers engaged in a lively discussion on trends in global healthcare collaboration. Among them was Ambassador George Hara, Group Chairman and CEO of DEFTA Partners and former Special Advisor to the Cabinet Office of the Prime Minister of Japan, who remarked that more advanced technology and new government regulations are needed to reach a compromise between companies' profits and patients' needs. During the Dialogue with Global Pioneer in Health session, Prof John Hardy, Chair of Molecular Biology of Neurological Disease of UCL Queen Square Institute of Neurology, shared his latest research findings and advanced developments in Alzheimer's disease. The summit co-organised sessions under the overarching theme, Shaping the Future of Healthcare, with the Hong Kong University of Science and Technology for the first time. The discussion focused on the potential of AI in healthcare and how innovation could drive breakthroughs in the field. Dr Alex Ng, President of Tencent Healthcare, commented: 'One uniqueness of tech companies is that they can be easily distracted by the latest thing. But you do need companies with patience and perseverance to stay in healthcare and make it work.' Prof Graham Cooke, Vice-Dean (Research) Medicine of Imperial College London, also noted that embedding patient needs into healthcare systems is critical, as many innovations fail in translation due to a lack of this focus, with universities playing a key role as innovation drivers. In Beyond 'Healthy China 2030': Driving Health Innovation, speakers explored opportunities in the mainland healthcare market. Marc Horn, Executive Vice President of Merck and President of Merck China, highlighted the two-phase approach of 'China for China' followed by 'China for the globe', emphasising healthcare collaboration to develop advanced treatments for global benefit. Dr Zhang Lianshan, Executive Vice President of Jiangsu Hengrui Pharmaceuticals Co., Ltd., stated: 'We would like to see our health innovation have realisation of its value, not only in China, but also outside of China. That is why we are talking about Globalisation, where we can achieve maximum value.' With growing global attention on healthy ageing, the summit introduced a dedicated Silver Health Chapter. A highlight was the thematic session titled Surfing the Silver Tsunami: Advancements in Geriatrics and Longevity Technology, where Prof Jean Woo, Director of Chinese University of Hong Kong Jockey Club Institute of Ageing, Prof James L. Kirkland, Director of Cedars-Sinai's Centre for Advanced Gerotherapeutics, and fellow experts explored both the challenges and opportunities posed by ageing populations. Prof Jean Woo highlighted that rapid population ageing is reshaping the global healthcare and socioeconomic landscape. As a city with one of the world's longest life expectancies, Hong Kong must take early action to strengthen elderly care policies and better allocate health resources. Prof James L. Kirkland also noted that geriatricians ultimately aim to help patients with multiple illnesses reduce medication use while treating their conditions more effectively, enhancing their overall quality of life. Over 390 deal-making sessions and cooperation agreements open new global opportunities A key feature of the summit was the ASGH Deal-Making session, which facilitated one-on-one meetings both online and offline, aiming to connect investors and projects in the healthcare sector from around the world to promote global collaborations. Investment projects spanned pharmaceuticals, medical devices and diagnostics, smart healthcare, and community health and wellness and more than 390 one-on-one meetings were successfully arranged for angel investors, venture capitalists, corporate venture arms, private equity firms and family offices. The summit facilitated the signing of cooperation agreements, such as those between Gleneagles Hospital Hong Kong and Emerging Viral Diagnostics, and a tripartite collaboration with PanopticAI and SmartCare, HKSH Medical Group and United Imaging Healthcare, China Resources Guangdong Pharmaceuticals and Hong Kong Medtech Association, Hugobiotech and Bridgeway Healthcare Technology, Canossa Hospital and KA Imaging, and others. These agreements covered diverse healthcare areas, including patient care, diagnostic solutions, innovative medical devices, medical imaging and more. Under the tripartite collaboration agreement between Gleneagles Hospital Hong Kong, PanopticAI, and SmartCare, the integration of PanopticAI's camera-based vital signs monitoring technology and SmartCare's patient-centered consultation platform will be implemented into Gleneagles clinic in the future. In addition to its discussion sessions, the summit also featured the ASGH Business Hub, showcasing more than 170 innovative technology companies related to the healthcare industry from 13 countries and regions, including the mainland (Shanghai and Xiamen), Australia, and Thailand, presenting projects and solutions across key areas such as medical innovation, smart healthcare, AI, big data, telemedicine, and cybersecurity. Zhong Wei, Co-founder of Mitrassist Lifesciences, joined the Shanghai Pavilion and said that ASGH helped them bring non-invasive medical monitoring technologies to Southeast Asia, Africa, and other Belt and Road Initiative countries. Medical Fair Drives Industry Innovation and Fosters Business Collaboration The Medical Fair, organised by the HKTDC and co-organised by the Hong Kong MedTech Association, was held alongside ASGH. The Association—formerly known as the Hong Kong Medical and Healthcare Device Industries Association—held a renaming ceremony during the fair, showcasing the deep integration of medical technology and the industry. The fair brought together some 300 exhibitors from 13 countries and regions, featuring first-time pavilions from the United Kingdom, Thailand and Israel, along with debut exhibitors from Singapore, Germany, Italy and Luxembourg. In addition, seven local universities, over 30 innovative technology companies at the Hong Kong Science and Technology Parks pavilion, and more than 20 medical enterprises brought by the Hong Kong MedTech Association participated. The Hong Kong Council of Social Service also participated in the fair for the first time. Under the theme Innovations Boosting Smart Health Experience, the exhibition spotlighted three major areas: MedTech, GeronTech and green solutions, with many exhibits featuring applications of AI. Many exhibitors and buyers successfully expanded their networks and forged new partnerships at the exhibition. Among them was Hong Kong exhibitor Eieling Technology, a company founded to commercialise research outcomes from the Hong Kong Polytechnic University. The firm showcased its non-invasive liver examination technology, which utilises transient elastography technology. Co-founder and CEO Xiaojia Jia noted that only about four companies worldwide possess this technology, making it a major draw for buyers. 'During the exhibition, we received intention orders worth several million Hong Kong dollars from mainland China, Hong Kong, Indonesia, and Thailand, involving around ten devices. This is our third year participating, and we've observed a significant rise in buyers' professionalism during our discussions. We look forward to exhibiting again next year.' Karel Lee, CEO of Neoneco from Korea, sourced innovative medical products at the fair with a minimum budget of USD100,000 and he has already identified RhinoCare, an exhibitor from the Israeli pavilion, for its nasal decongestion device, and is also interested in a medical examination device from a Hong Kong exhibitor. Lee stated, 'The exhibition allows us to meet with exhibitors face-to-face, build trust, and accelerate the decision-making process. The HKTDC's Click2Match platform also facilitated efficient business matching. I have already connected with ten exhibitors, and another twenty reached out to me after learning about my sourcing needs. This is one of Asia's premium medical sourcing events, and we will definitely return next year.' Beyond business deals, insightful forums were arranged during the Medical Fair to give inspiration to industry buyers. These included The Latest Development of Regulatory Collaboration on Medical Devices in the Greater Bay Area, The MedTech Nexus of the Greater Bay Area, co-organised with the Hong Kong MedTech Association, and Fostering Silver Economy, Leading Quality Elderly & Rehabilitation Care Practices, co-organised with the HKCSS. These forums attracted a strong attendance and offered valuable insights into healthcare. Selected sessions are available for replay on the Fair's website for extended engagement. This year's Fair continued to adopt the EXHIBITION+ hybrid model. Global exhibitors, industry professionals, and buyers could make use of the Click2Match and explore sourcing opportunities via HKTDC Sourcing ( Sourcing). Click2Match will remain available until 4 June. Websites International Healthcare Week: Asia Summit On Global Health: Hong Kong International Medical and Healthcare Fair: Photo download: Media enquiries For enquiries, please contact Yuan Tung Financial Relations Limited: HKTDC's Communications & Public Affairs Department: Asia Summit on Global Health Hong Kong International Medical and Healthcare Fair Media Room: About HKTDC The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit:
